Unicycive Announces Renazorb Pre-clinical and Clinical Data Selected for Presentation at National Kidney Foundation Spring Clinical Meeting

/PRNewswire/ -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical stage biotechnology company developing therapies for patients with kidney disease,...

Related Keywords

Boston ,Massachusetts ,United States ,Shalabh Gupta ,National Kidney Foundation ,Prnewswire Unicycive Therapeutics Inc ,Drug Administration ,Nasdaq ,Spring Clinical Meeting ,Chief Executive ,Clinical Meeting ,Dioxycarbonate Effectively Reduces Phosphate ,Unicycive Therapeutics Inc ,